Service screening with mammography in Northern Sweden:: effects on breast cancer mortality -: an update

被引:58
|
作者
Jonsson, Hakan [1 ]
Bordas, Pal
Wallin, Hans
Nystrom, Lennarth
Lenner, Per
机构
[1] Umea Univ Hosp, Ctr Oncol, Dept Radiat Sci Oncol, S-90185 Umea, Sweden
[2] Sundby Hosp, Mammog Screening Program Norrbotten, Lulea, Sweden
[3] Umea Univ, Epidemiol & Publ Hlth Sci Dept, Umea, Sweden
[4] Umea Univ, Dept Radiat Sci Oncol, Umea, Sweden
关键词
D O I
10.1258/096914107781261918
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To study the effectiveness of service screening with mammography in Northern Sweden. Setting Two counties which invited women aged 40-74 years to service screening with mammography were compared with two counties where service screening started 5-7 years later. There were 109,000 and 77,000 women in the study and control counties, respectively. Methods Cohorts in the study group were defined to include only breast cancer cases diagnosed after their first invitation to screening. Two outcome measures for breast cancer mortality were used; excess mortality and underlying cause of death (UCD). Detection mode was used to estimate the efficacy of screening for those women who actually attended screening. The cohorts were followed for 11 years. Results The relative rate (RR) of breast cancer death as excess mortality and UCD for women aged 40-74 years invited to screening, compared with women not yet invited, was 0.70 (95% confidence interval [CI] 0.56-0.87) and 0.74 (95% CI 0.62-0.88), respectively. The largest effect was seen in women aged 40-49 years (RR = 0.64 and RR = 0.62 for excess mortality and UCD, respectively). RR in age 40-74 years for women actually screened was 0.65 (95% CI 0.51-0.84) and 0.70 (95% CI 0.57-0.86) for excess mortality and UCD, respectively. The number of women needed to screen to save one life was 912 after 11 years of follow-up. Conclusions This study confirms previous findings in the earlier follow-up and indicates a long-term reduction of breast cancer mortality by 26-30%. The efficacy among those who actually attended screening was about 5% larger.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 50 条
  • [21] Mammography Screening and Breast Cancer Mortality-Letter
    Autier, Philippe
    Boniol, Mathieu
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (05) : 869 - 869
  • [22] Mammography screening nearly halves breast cancer mortality
    Mayor, S
    BRITISH MEDICAL JOURNAL, 2003, 326 (7396): : 949 - 949
  • [23] Mammography screening contributes to decreases in advanced breast cancer and breast cancer mortality
    Otto, S. J.
    Fracheboud, J.
    Verbeek, A. L. M.
    Broeders, M. J. M.
    De Koning, H. J.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 125 - 125
  • [24] Effect of service screening mammography on population mortality from breast carcinoma
    Feig, SA
    CANCER, 2002, 95 (03) : 451 - 457
  • [25] Mammography service screening and mortality - Reply
    Tabar, L
    Duffy, SW
    Smith, RA
    LANCET, 2003, 362 (9380): : 330 - 330
  • [26] Modern mammography screening and breast cancer mortality: population study
    Weedon-Fekjaer, Harald
    Romundstad, Pal R.
    Vatten, Lars J.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [27] Breast cancer mortality in Norway after the introduction of mammography screening
    Olsen, Anne Helene
    Lynge, Elsebeth
    Njor, Sisse H.
    Kumle, Merethe
    Waaseth, Marit
    Braaten, Tonje
    Lund, Eiliv
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 208 - 214
  • [28] Effect of Screening Mammography on Breast-Cancer Mortality in Norway
    Kalager, Mette
    Zelen, Marvin
    Langmark, Froydis
    Adami, Hans-Olov
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (13): : 1203 - 1210
  • [29] Impact of Mammography Screening Frequency on Breast Cancer Mortality Rates
    Abu Abeelh, Enas
    Abuabeileh, Zain
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [30] Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
    Autier, Philippe
    Hery, Clarisse
    Haukka, Jari
    Boniol, Mathieu
    Byrnes, Graham
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5919 - 5923